Vitamin D deficiency in patients with Behcet's disease

Journal of Diabetes and Metabolic Disorders

Volumn 13, Issue 1, 2014, Pages

  Faezi, Seyedeh T ^a   Ansari, Narges ^a   Paragomi, Pedram ^a   Akhlaghi, Maassoumeh ^a   Ghanavat, Majid ^a   Davatchi, Fereydoun ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Behcet's disease; Internal medicine; Vitamin D

Indexed keywords

HLA B ANTIGEN; HLA B5 ANTIGEN; HLA B51 ANTIGEN; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; AGED; ARTICLE; BEHCET DISEASE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHERGY TEST; PREVALENCE; SEX DIFFERENCE; SKIN TEST; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84908121689     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/2251-6581-13-18     Document Type: Article

References (39)

1. Saadoun D, Wechsler B. Behcet's disease. Orphanet J Rare Dis 2012, 7:20. 10.1186/1750-1172-7-20, 3472229, 22497990.
2. Pineton de Chambrun M, Wechsler B, Geri G, Cacoub P, Saadoun D. New insights into the pathogenesis of Behcet's disease. Autoimmun Rev 2012, 11(10):687-698. 10.1016/j.autrev.2011.11.026, 22197900.
3. Feigenbaum A. Description of Behcet's syndrome in the Hippocratic third book of endemic diseases. Br J Ophthalmol 1956, 40(6):355-357. 10.1136/bjo.40.6.355, 509495, 13355940.
4. Mutlu S, Scully C. The person behind the eponym: Hulusi Behcet (1889-1948). J Oral Pathol Med 1994, 23(7):289-290. 10.1111/j.1600-0714.1994.tb00063.x, 7965882.
5. Kaneko F, Nakamura K, Sato M, Tojo M, Zheng X, Zhang JZ. Epidemiology of Behcet's disease in Asian countries and Japan. Adv Exp Med Biol 2003, 528:25-29.
6. Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, et al. Population-based prevalence study of Behcet's disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 2008, 58(12):3951-3959. 10.1002/art.24149, 19035493.
7. Davatchi F, Jamshidi AR, Banihashemi AT, Gholami J, Forouzanfar MH, Akhlaghi M, et al. WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran. J Rheumatol 2008, 35(7):1384.
8. Gul A. Behcet's disease: an update on the pathogenesis. Clin Exp Rheumatol 2001, 19(5 Suppl 24):S6-S12.
9. Protogerou AD, Sfikakis PP, Stamatelopoulos KS, Papamichael C, Aznaouridis K, Karatzis E, et al. Interrelated modulation of endothelial function in Behcet's disease by clinical activity and corticosteroid treatment. Arthritis Res Ther 2007, 9(5):R90. 10.1186/ar2289, 2212573, 17845731.
10. Zouboulis CC, May T. Pathogenesis of Adamantiades-Behcet's disease. Adv Exp Med Biol 2003, 528:161-171.
11. Li YC, Bolt MJ, Cao LP, Sitrin MD. Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism. Am J Physiol Endocrinol Metab 2001, 281(3):E558-E564.
12. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006, 5(2):114-117. 10.1016/j.autrev.2005.05.009, 16431339.
13. Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000, 374(2):334-338. 10.1006/abbi.1999.1605, 10666315.
14. Lemire JM. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 1992, 49(1):26-31. 10.1002/jcb.240490106, 1644850.
15. Penna G, Roncari A, Amuchastegui S, Daniel KC, Berti E, Colonna M, et al. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4 + Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. Blood 2005, 106(10):3490-3497. 10.1182/blood-2005-05-2044, 16030186.
16. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001, 167(4):1945-1953.
17. Lemire JM, Adams JS, Sakai R, Jordan SC. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984, 74(2):657-661. 10.1172/JCI111465, 370520, 6611355.
18. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A 2001, 98(12):6800-6805. 10.1073/pnas.121172198, 34433, 11371626.
19. Cantorna MT. Vitamin D, and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence?. Proc Soc Exp Biol Med 2000, 223(3):230-233. 10.1046/j.1525-1373.2000.22333.x, 10719834.
20. Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B. Vitamin D in rheumatoid arthritis. Autoimmun Rev 2007, 7(1):59-64. 10.1016/j.autrev.2007.07.001, 17967727.
21. O'Regan S, Chesney RW, Hamstra A, Eisman JA, O'Gorman AM, Deluca HF. Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus. Acta Paediatr Scand 1979, 68(1):109-111.
22. Teichmann J, Lange U, Stracke H, Federlin K, Bretzel RG. Bone metabolism and bone mineral density of systemic lupus erythematosus at the time of diagnosis. Rheumatol Int 1999, 18(4):137-140. 10.1007/s002960050072, 10220833.
23. Basit S. Vitamin D in health and disease: a literature review. Br J Biomed Sci 2013, 70(4):161-72.
24. Arabi A, El Rassi R, El-Hajj FG. Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat Rev Endocrinol 2010, 6(10):550-561. 10.1038/nrendo.2010.146, 20852586.
25. Heshmat R, Larijani B. Vitamin D deficiency in Iran. Iranian J Public Health 2008, 1:72-78.
26. Hashemipour BL. Vitamin D deficiency and causative factors in the population of Tehran. Public Health 2004, 4:38. 517720, 15327695.
27. Lips P. Vitamin D, status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 2007, 103(3-5):620-625.
28. Gannage-Yared MH, Chemali R, Yaacoub N, Halaby G. Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers. J Bone Miner Res 2000, 15(9):1856-1862. 10.1359/jbmr.2000.15.9.1856, 10977006.
29. Do JE, Kwon SY, Park S, Lee ES. Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease. Rheumatology (Oxford) 2008, 47(6):840-848. 10.1093/rheumatology/ken109, 18411217.
30. Mahon BD, Wittke A, Weaver V, Cantorna MT. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 2003, 89(5):922-932. 10.1002/jcb.10580, 12874827.
31. Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J 2001, 15(14):2579-2585. 10.1096/fj.01-0433rev, 11726533.
32. Pelajo CF, Lopez-Benitez JM, Miller LC. Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev 2010, 9(7):507-510. 10.1016/j.autrev.2010.02.011, 20146942.
33. O'Connell K, Kelly S, Kinsella K, Jordan S, Kenny O, Murphy D, et al. Dose-related effects of vitamin D on immune responses in patients with clinically isolated syndrome and healthy control participants: study protocol for an exploratory randomized double- blind placebo-controlled trial. Trials 2013, 14(1):272. 10.1186/1745-6215-14-272, 3844318, 23981773.
34. Hamzaoui K, Ben Dhifallah I, Karray E, Sassi FH, Hamzaoui A. Vitamin D modulates peripheral immunity in patients with Behcet's disease. Clin Exp Rheumatol 2010, 28(4 Suppl 60):S50-S57.
35. Khabbazi A, Rashtchizadeh N, Ghorbanihaghjo A, Hajialiloo M, Ghojazadeh M, Taei R, et al. The status of serum vitamin D in patients with active Behcet's disease compared with controls. Int J Rheum Dis 2013, In Press: Article first published online.
36. Can M, Gunes M, Haliloglu OA, Haklar G, Inanc N, Yavuz DG, et al. Effect of vitamin D deficiency and replacement on endothelial functions in Behcet's disease. Clin Exp Rheumatol 2012, 30(3 Suppl 72):S57-S61.
37. Kandi B, Cicek D, Ilhan N. Vitamin levels in Behcet's disease. J Dermatolog Treat 2007, 18(2):69-75. 10.1080/09546630601156355, 17520462.
38. Bonakdar ZS, Jahanshahifar L, Jahanshahifar F, Gholamrezaei A. Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus 2011, 20(11):1155-1160. 10.1177/0961203311405703, 21680639.
39. Heidari B, Hajian-Tilaki K, Heidari P. The status of serum vitamin D in patients with rheumatoid arthritis and undifferentiated inflammatory arthritis compared with controls. Rheumatol Int 2012, 32(4):991-995. 10.1007/s00296-010-1736-3, 21246367.